| Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer Y Xu, Z Xiang, M Alnaggar, L Kouakanou, J Li, J He, J Yang, Y Hu, ... Cellular & molecular immunology 18 (2), 427-439, 2021 | 152 | 2021 |
| Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma M Alnaggar, Y Xu, J Li, J He, J Chen, M Li, Q Wu, L Lin, Y Liang, X Wang, ... Journal for immunotherapy of cancer 7, 1-7, 2019 | 109 | 2019 |
| Irreversible electroporation plus allogenic Vγ9Vδ2 T cells enhances antitumor effect for locally advanced pancreatic cancer patients M Lin, X Zhang, S Liang, H Luo, M Alnaggar, A Liu, Z Yin, J Chen, L Niu, ... Signal Transduction and Targeted Therapy 5 (1), 215, 2020 | 70 | 2020 |
| Allogenic natural killer cell immunotherapy combined with irreversible electroporation for stage IV hepatocellular carcinoma: survival outcome M Alnaggar, M Lin, A Mesmar, S Liang, A Qaid, K Xu, J Chen, L Niu, Z Yin Cellular Physiology and Biochemistry 48 (5), 1882-1893, 2018 | 56 | 2018 |
| Percutaneous irreversible electroporation for ablation of locally advanced pancreatic cancer: experience from a Chinese institution Y Zhang, J Shi, J Zeng, M Alnagger, L Zhou, G Fang, Z Pan, Y Li, J Chen, ... Pancreas 46 (2), e12-e14, 2017 | 40 | 2017 |
| An important discovery on combination of irreversible electroporation and allogeneic natural killer cell immunotherapy for unresectable pancreatic cancer M Lin, M Alnaggar, S Liang, X Wang, Y Liang, M Zhang, J Chen, L Niu, ... Oncotarget 8 (60), 101795, 2017 | 39 | 2017 |
| Silver nanoparticles induce cell death of colon cancer cells through impairing cytoskeleton and membrane nanostructure H Xiao, Y Chen, M Alnaggar Micron 126, 102750, 2019 | 34 | 2019 |
| Circulating tumor DNA as a sensitive marker in patients undergoing irreversible electroporation for pancreatic cancer M Lin, M Alnaggar, S Liang, J Chen, K Xu, S Dong, D Du, L Niu Cellular Physiology and Biochemistry 47 (4), 1556-1564, 2018 | 23 | 2018 |
| Irreversible electroporation of malignant liver tumors: Effect on laboratory values M Alnaggar, AM Qaid, J Chen, L Niu, K Xu Oncology Letters 16 (3), 3881-3888, 2018 | 10 | 2018 |
| Fatty Infiltration of the Pancreas: A Systematic Concept Analysis MA Mahyoub, M Elhoumed, AH Maqul, M Almezgagi, M Abbas, Y Jiao, ... Frontiers in Medicine 10, 1227188, 2023 | 7 | 2023 |
| Allogeneic Vγ9Vδ2 T-cell therapy promotes pulmonary lesion repair: an open-label, single-arm pilot study in patients with multidrug-resistant tuberculosis J Liang, L Fu, M Li, Y Chen, Y Wang, Y Lin, H Zhang, Y Xu, L Qin, J Liu, ... Frontiers in immunology 12, 756495, 2021 | 7 | 2021 |
| Cryoprotective therapy for huge hepatocellular carcinoma: A study of 14 patients with a single lesion M Alnaggar, L Niu, J Li, F Yao, Y Wang, J Zeng, J Ye, J Chen, F Mu, K Xu Cryobiology 69 (3), 457-461, 2014 | 7 | 2014 |
| Cryoprotective therapy for hepatocellular carcinoma: Study of 51 patients with a single lesion AMA Ali, N Lizhi, L Jialiang, Y Fei, W Yuan, Z Jianying, Y Jin, C Jibing, ... Cryobiology 69 (1), 61-67, 2014 | 6 | 2014 |
| Fecal microbiota transplantation plus tislelizumab and fruquintinib in refractory microsatellite stable metastatic colorectal cancer: an open-label, single-arm, phase II trial … W Zhao, J Lei, S Ke, Y Chen, J Xiao, Z Tang, L Wang, Y Ren, M Alnaggar, ... Eclinicalmedicine 66, 2023 | 4 | 2023 |
| Using circulating tumor cells to evaluate the efficacy of irreversible electroporation for unresectasble pancreatic cancer M Lin, M Alnaggar, SZ Liang, J Shi, LZ Niu, JB Chen, KC Xu Immunologic Research 66, 172-178, 2018 | 2 | 2018 |
| Circulating Tumor DNA as a Sensitive Marker in Patients Undergoing Irreversible Electroporation for Pancreatic Cancer (vol 47, pg 1556, 2018) M Li, M Alnaggar, S Liang, J Chen, K Xu, S Dong, D Du, L Niu, Z Yin CELLULAR PHYSIOLOGY AND BIOCHEMISTRY 48 (3), 1397-1397, 2018 | 2 | 2018 |
| Clinical analysis of pregnancy associated with acute pancreatitis M Alnaggar Int J Adv Med 3 (4), 799-803, 2016 | 2 | 2016 |
| Allogeneic Vg9Vd2 T-Cell Therapy Promotes Pulmonary Lesion Repair: An Open-Label, Single-Arm Pilot Study in Patients With Multidrug-Resistant Tuberculosis J Liang, L Fu, M Li, Y Chen, Y Wang, Y Lin, H Zhang, Y Xu, L Qin, J Liu, ... Moving Towards Allogeneic Cellular Therapies: Opportunities and Challenges, 2022 | 1 | 2022 |
| HEPATOCELLULAR CARCINOMA TREATMENT; NONSURGICAL APPROACHES M Alnaggar International Journal of Current Research and Review 8 (16), 1, 2016 | 1 | 2016 |
| Safety and efficacy of fecal microbiota transplantation for cytotoxic chemotherapy–induced diarrhea management in patients with colorectal cancer: a single-arm clinical trial M Alnaggar, MA Mahyoub, W Cheng, W Huang, Y Xu, S Wang, ... | | 2024 |
Yangzhe Wu@吴扬哲, PhD, ProfessorZhuhai People's HospitalVerified email at jnu.edu.cn
